Clinical Trial Update: Droperidol on Prevention of Cannabis Hyperemesis Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating droperidol for prevention of cannabis hyperemesis syndrome is in progress, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Hyperemesis Syndrome

Drugs mentioned

• Droperidol (droperidol)

Snippet

Sponsor: Mercy Health Ohio | Conditions: Cannabis Hyperemesis Syndrome | Phase 3 | Status: UNKNOWN